by Vora Corporate Finance | Sep 1, 2025 | Insights, Private Equity & IPO
Transaction: PE firm TPG, through its growth equity platform TPG Growth, has entered into a binding agreement to acquire a 35% stake in SCHOTT Poonawalla from Serum Institute of India (SII), with Danish investor Novo Holdings as a co-investor. The total investment is...
by Vora Corporate Finance | Sep 1, 2025 | Insights
Transaction: Unipath Specialty Laboratory Ltd (USLL), a leading diagnostic brand in Western India backed by the promoters of Intas Pharmaceuticals Ltd, has acquired 100% equity in Ravula Health Care Private Limited. The deal was structured in multiple independent...
by Vora Corporate Finance | Aug 19, 2025 | Insights
India Retains Fastest-Growing Economy Tag with 7.4% Q4 Surge, Set to Overtake Japan in 2025 India’s economy maintained its momentum in FY 2024-25, clocking a robust real GDP growth of 6.5%, supported by an impressive 7.4% expansion in Q4. According to the IMF, India...
by Vora Corporate Finance | Aug 19, 2025 | Insights, Private Equity & IPO
Transaction: SRV Hospitals, a Mumbai-based multi-specialty hospital chain, has raised INR 140 crores in funding from InvAscent, a leading private equity fund focused on the life sciences sector. The funding will support SRV’s growth strategy, centered on its...
by Vora Corporate Finance | Aug 19, 2025 | Insights
There were no main board IPOs in March and April 2025. There were 05 SME IPOs in April 2025 as against 07 SME IPOs in March 2025. India’s IPO market began 2025 on a subdued note, with only 10 mainboard listings as companies held back amid market volatility, global...
